Trial intelligence / Profile preview

VivaGel (SPL7013) in Bacterial Vaginosis

NCT01201057Phase 2Completed

Sponsor
Starpharma
Start
Aug 2010
Primary completion
Mar 2011
Modality
Peptides, Polymer-based Nanoparticles
Countries
1
01

Overview

A Phase 2 trial of astodrimer in bacterial vaginosis (BV), sponsored by Starpharma. Started Aug 2010; status: completed.

02

Drugs

astodrimer
03

Conditions

bacterial vaginosis (BV)

Beyond the preview

Go deeper on NCT01201057.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01201057.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call